/biz/ - Business & Finance

>>54044598
>Why can't other pharmaceutical companies sell obesity drugs? Insulin patents don't apply here.

See https://www.novonordisk-us.com/products/product-patents.html

One such example: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/10888605 where Section 4, line 27 covers semaglutide's use for obesity. Note that this list of patents is explicitly for Wegovy (obesity), separate from Ozempic (diabeetus).

Which isn't to say there isn't competition in the space (from, say, LLY's Mounjaro) but it's not like they're trying to profit off bog standard insulin or something.